M. Axel Wollmer

4.1k total citations · 1 hit paper
56 papers, 2.9k citations indexed

About

M. Axel Wollmer is a scholar working on Neurology, Physiology and Molecular Biology. According to data from OpenAlex, M. Axel Wollmer has authored 56 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Neurology, 18 papers in Physiology and 14 papers in Molecular Biology. Recurrent topics in M. Axel Wollmer's work include Alzheimer's disease research and treatments (15 papers), Botulinum Toxin and Related Neurological Disorders (14 papers) and Neurological disorders and treatments (10 papers). M. Axel Wollmer is often cited by papers focused on Alzheimer's disease research and treatments (15 papers), Botulinum Toxin and Related Neurological Disorders (14 papers) and Neurological disorders and treatments (10 papers). M. Axel Wollmer collaborates with scholars based in Germany, Switzerland and United States. M. Axel Wollmer's co-authors include Roger M. Nitsch, Andreas Papassotiropoulos, Christoph Höck, Dominique J.‐F. de Quervain, Katharina Henke, Tillmann H. C. Krüger, Jay Tracy, Johannes Streffer, Eva Moritz and M. Hasan Mohajeri and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

M. Axel Wollmer

53 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antibodies against β-Amyloid Slow Cognitive Decline in Alzheimer's Disease

2003 581 citations Christoph Höck, Uwe Konietzko et al. Neuron profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Axel Wollmer Germany	25	1.3k	954	474	474	408	56	2.9k
Johannes Streffer Belgium	30	1.6k 1.3×	1.1k 1.2×	536 1.1×	526 1.1×	461 1.1×	77	3.4k
Liying Han China	21	1.4k 1.1×	943 1.0×	540 1.1×	587 1.2×	256 0.6×	51	3.2k
Amalia C. Bruni Italy	30	899 0.7×	1.0k 1.1×	521 1.1×	379 0.8×	441 1.1×	104	2.5k
Shannon L. Macauley United States	25	1.9k 1.5×	981 1.0×	433 0.9×	535 1.1×	198 0.5×	49	3.4k
Silvia Bagnoli Italy	29	1.0k 0.8×	814 0.9×	363 0.8×	342 0.7×	229 0.6×	135	2.4k
Sylvia E. Perez United States	32	1.6k 1.3×	986 1.0×	929 2.0×	685 1.4×	212 0.5×	79	3.4k
Maria Barcikowska Poland	36	1.7k 1.3×	1.5k 1.6×	458 1.0×	823 1.7×	683 1.7×	161	3.8k
Stavros Balogiannis Greece	28	1.1k 0.9×	804 0.8×	610 1.3×	577 1.2×	400 1.0×	146	2.8k
Lynn M. Bekris United States	26	1.3k 1.0×	1.0k 1.1×	358 0.8×	910 1.9×	384 0.9×	52	3.0k
Nilüfer Ertekin‐Taner United States	30	1.6k 1.2×	1.2k 1.2×	283 0.6×	453 1.0×	366 0.9×	108	2.8k

Countries citing papers authored by M. Axel Wollmer

Since Specialization

Citations

This map shows the geographic impact of M. Axel Wollmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Axel Wollmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Axel Wollmer more than expected).

Fields of papers citing papers by M. Axel Wollmer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Axel Wollmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Axel Wollmer. The network helps show where M. Axel Wollmer may publish in the future.

Co-authorship network of co-authors of M. Axel Wollmer

This figure shows the co-authorship network connecting the top 25 collaborators of M. Axel Wollmer. A scholar is included among the top collaborators of M. Axel Wollmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Axel Wollmer. M. Axel Wollmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sinke, Christopher, et al.. (2023). Effects of glabellar botulinum toxin injections on resting-state functional connectivity in borderline personality disorder. European Archives of Psychiatry and Clinical Neuroscience. 274(1). 97–107. 1 indexed citations

Krüger, Tillmann H. C., et al.. (2023). Botulinum Toxin Therapy for Psychiatric Disorders in Clinical Practice: A Retrospective Case Study. Toxins. 15(6). 385–385. 5 indexed citations

Chugh, Sanjay, et al.. (2018). Botulinum Toxin as a Treatment for Depression in a Real-world Setting. Journal of Psychiatric Practice. 24(1). 15–20. 22 indexed citations

Finzi, Eric, et al.. (2018). Botulinum toxin therapy of bipolar depression: A case series. Journal of Psychiatric Research. 104. 55–57. 9 indexed citations

Sinke, Christopher, M. Axel Wollmer, Jonas Kneer, Kai G. Kahl, & Tillmann H. C. Krüger. (2017). Interaction between behavioral inhibition and emotional processing in borderline personality disorder using a pictorial emotional go/no-go paradigm. Psychiatry Research. 256. 286–289. 9 indexed citations

Wollmer, M. Axel, et al.. (2015). The Hamburg–Hannover Agitation Scale (H2A): Development and validation of a self-assessment tool for symptoms of agitation. Journal of Psychiatric Research. 69. 158–165. 4 indexed citations

Magid, Michelle, et al.. (2014). Treatment of Major Depressive Disorder Using Botulinum Toxin A. The Journal of Clinical Psychiatry. 75(8). 837–844. 85 indexed citations

Winter, Lotta, Tillmann H. C. Krüger, Jean Laurens, et al.. (2012). Vestibular Stimulation on a Motion-Simulator Impacts on Mood States. Frontiers in Psychology. 3. 499–499. 33 indexed citations

Kulic, Luka, M. Axel Wollmer, Virginie Rhein, et al.. (2009). Combined expression of tau and the Harlequin mouse mutation leads to increased mitochondrial dysfunction, tau pathology and neurodegeneration. Neurobiology of Aging. 32(10). 1827–1838. 26 indexed citations

10.

Papassotiropoulos, Andreas, Dietrich Stephan, Matthew J. Huentelman, et al.. (2006). Common Kibra Alleles Are Associated with Human Memory Performance. Science. 314(5798). 475–478. 312 indexed citations

11.

Wollmer, M. Axel, Roger M. Nitsch, Christoph Höck, & Andreas Papassotiropoulos. (2006). Genetic Association Study on Colony-Stimulating Factor 1 in Alzheimer’s Disease. Neurodegenerative Diseases. 3(6). 334–337. 4 indexed citations

12.

Papassotiropoulos, Andreas, M. Axel Wollmer, Adriano Aguzzi, et al.. (2005). The prion gene is associated with human long-term memory. Human Molecular Genetics. 14(15). 2241–2246. 73 indexed citations

13.

Schultz, Jan, Ulrich Salzer, M. Hasan Mohajeri, et al.. (2004). Antibodies from a DNA peptide vaccination decrease the brain amyloid burden in a mouse model of Alzheimer?s disease. Journal of Molecular Medicine. 82(10). 706–714. 24 indexed citations

14.

Mohajeri, M. Hasan, Julia Martínez, Jay Tracy, et al.. (2004). Assessment of the Bioactivity of Antibodies against β-Amyloid Peptide in vitro and in vivo. Neurodegenerative Diseases. 1(4-5). 160–167. 11 indexed citations

15.

Mohajeri, M. Hasan, Michael Huber, M. Axel Wollmer, et al.. (2004). Active Immunization of Mice with an <i>Aβ-Hsp70</i> Vaccine. Neurodegenerative Diseases. 1(1). 20–28. 16 indexed citations

16.

Papassotiropoulos, Andreas, Magda Tsolaki, M. Axel Wollmer, et al.. (2004). No association of a non‐synonymous PLAU polymorphism with Alzheimer's disease and disease‐related traits. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 132B(1). 21–23. 13 indexed citations

17.

Höck, Christoph, Uwe Konietzko, Johannes Streffer, et al.. (2003). Antibodies against β-Amyloid Slow Cognitive Decline in Alzheimer's Disease. Neuron. 38(4). 547–554. 581 indexed citations breakdown →

18.

Wollmer, M. Axel. (2003). ABCA1 modulates CSF cholesterol levels and influences the age at onset of Alzheimer's disease. Neurobiology of Aging. 24(3). 421–426. 125 indexed citations

19.

Wollmer, M. Axel, Johannes Streffer, Magda Tsolaki, et al.. (2003). Genetic association of acyl-coenzyme A: cholesterol acyltransferase with cerebrospinal fluid cholesterol levels, brain amyloid load, and risk for Alzheimer's disease. Molecular Psychiatry. 8(6). 635–638. 50 indexed citations

20.

Mohajeri, M. Hasan, et al.. (2002). Passive Immunization against β-Amyloid Peptide Protects Central Nervous System (CNS) Neurons from Increased Vulnerability Associated with an Alzheimer’s Disease-causing Mutation. Journal of Biological Chemistry. 277(36). 33012–33017. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact